《半日總結》恆指跌121點 車股及內需弱 內房回吐
中央經濟工作會議強調進一步推動經濟回升向好,明年堅持穩中求進,一視同仁滿足不同所有制房企合理融資需求等。港股早市在觀望美聯儲議息結果下偏軟,恆指低開62點後向下,曾跌154點見16,219點,半日跌121點或0.7%,報16,252點;國指跌56點或1%,報5,558點;恆生科技指數跌30點或0.8%,報3,699點。大市半日成交總額369.44億元,滬、深港通南下交易半日淨流入12.84億及9.2億元人民幣。
內房股昨日(12日)抽高後回吐,越秀地產(00123.HK)、旭輝(00884.HK)、合景泰富(01813.HK)及融創中國(01918.HK)跌6.6%至7.4%,綠城中國(03900.HK)跌5.1%,中海外(00688.HK)、龍湖(00960.HK)及潤地(01109.HK)跌3%至3.5%。碧桂園(02007.HK)據報料可避免首次境內債違約,股價升1.3%。
中汽協指上月新能源汽車出口按月跌22%,車股受壓。蔚來-SW(09866.HK)及小鵬-W(09868.HK)跌5%及6.6%,比亞迪(01211.HK)跌2%報203.2元。理想-W(02015.HK)披露本月銷量已達1.3萬輛,股價仍跌2.5%。中央經濟工作會議提出著力擴大內需,但內需股走軟,康師傅(00322.HK)、潤啤(00291.HK)、安踏(02020.HK)、李寧(02331.HK)均跌逾3%,維達(03331.HK)、青啤(00168.HK)及中免(01880.HK)跌4.6%至5.7%。
科技股方面,阿里-SW(09988.HK)及騰訊(00700.HK)跌0.9%,京東-SW(09618.HK)及美團-W(03690.HK)跌2.3%及2.5%、網易-S(09999.HK)及小米-W(01810.HK)升1.5%及1.8%,百度-SW(09888.HK)跌0.4%。此外,東方甄選(01797.HK)及微盟(02013.HK)跌7.2%及9.6%,金蝶(00268.HK)及金山雲(03896.HK)跌逾3%。
美國能源信息署下調明年油價預測觸發油價下挫,中海油(00883.HK)跌2.4%。石藥(01093.HK)一項神經系統藥物獲藥監局批准開展臨床試驗,股價逆升0.9%,其餘藍籌方面,匯控(00005.HK)及港交所(00388.HK)跌0.2%及0.8%,友邦(01299.HK)升1%,招行(03968.HK)趺3.7%。
藥師幫(09885.HK)最大股東承諾禁售期後半年不減持,股價半日仍挫43.1%。科濟藥業-B(02171.HK)旗下藥物被美國監管當局叫停臨床試驗,股價挫26.9%。航空股國泰(00293.HK)升2%,大摩報告指本港至歐美空運費率急增,看好該股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.